These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27774765)

  • 21. Criteria for definition of hereditary breast cancer in a clinic perspective.
    Cortizo-Torres ME; Duarte F; Schmitt FC; Cameselle-Teijeiro JF; López-Touza A
    Breast J; 2002; 8(6):402-3. PubMed ID: 12390370
    [No Abstract]   [Full Text] [Related]  

  • 22. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
    Liang Y; Zhang H; Song X; Yang Q
    Semin Cancer Biol; 2020 Feb; 60():14-27. PubMed ID: 31421262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
    Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
    Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer.
    Kratz J; Burkard M; O'Meara T; Pusztai L; Veitch Z; Bedard PL
    Am Soc Clin Oncol Educ Book; 2018 May; 38():56-64. PubMed ID: 30231387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Heterogeneity in Breast Cancer.
    Badve S; Gökmen-Polar Y
    Adv Anat Pathol; 2015 Sep; 22(5):294-302. PubMed ID: 26262511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of breast imaging to screen women at high risk for cancer.
    Sickles EA
    Radiol Clin North Am; 2010 Sep; 48(5):859-78. PubMed ID: 20868890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity.
    Chen C; Peng J; Xia H; Wu Q; Zeng L; Xu H; Tang H; Zhang Z; Zhu X; Pang D; Li Y
    Nanotechnology; 2010 Mar; 21(9):095101. PubMed ID: 20110584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of genomic instability in the diagnosis and treatment of breast cancer.
    Wiechec E
    Expert Rev Mol Diagn; 2011 May; 11(4):445-53. PubMed ID: 21545260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Testing in Breast Cancer.
    Litton JK; Burstein HJ; Turner NC
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e1-e7. PubMed ID: 31099622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast MRI radiogenomics: Current status and research implications.
    Grimm LJ
    J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.
    Campoy EM; Branham MT; Mayorga LS; Roqué M
    BMC Cancer; 2019 Apr; 19(1):328. PubMed ID: 30953488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Heterogeneity in Breast Cancer.
    Turashvili G; Brogi E
    Front Med (Lausanne); 2017; 4():227. PubMed ID: 29276709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in molecular imaging for breast cancer detection and characterization.
    Specht JM; Mankoff DA
    Breast Cancer Res; 2012 Mar; 14(2):206. PubMed ID: 22423895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer intra-tumor heterogeneity.
    Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Familial breast cancer: what the radiologist needs to know].
    Kuhl CK
    Rofo; 2006 Jul; 178(7):680-7. PubMed ID: 16817122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomics and breast cancer screening.
    Tyler AL
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):485-487. PubMed ID: 31490845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.
    Gulbahce HE; Factor R; Geiersbach K; Downs-Kelly E
    Arch Pathol Lab Med; 2016 Aug; 140(8):741. PubMed ID: 27472230
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.
    Walker-Smith TL; Peck J
    Nurs Womens Health; 2019 Dec; 23(6):518-525. PubMed ID: 31669147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumour cells: insights into tumour heterogeneity.
    Hayes DF; Paoletti C
    J Intern Med; 2013 Aug; 274(2):137-43. PubMed ID: 23844916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.